Skip to content
OpenCapital
Get started

Bio-Rad Laboratories BIO Life Science — Net Sales

Other segment segments

Clinical Diagnostics
$363.6M+1.9%
All Other Segments
$0-100%

Similar metrics at other companies

Revvity logo
RVTYLife Sciences — Segment revenue
$361.85M+6.3%
STERIS logo
STELife Sciences: — Revenue
$145.8M+6.9%
STERIS logo
STELife Science Member — Revenue
$135.2M+5.2%
Revvity logo
RVTYLife Sciences — Revenue from Contract with Customer, Excluding Assessed Tax
$361.85M+6.3%
Donaldson Company logo
DCILife Sciences Segment — Net Sales
$83.5M+12.5%
PEA
PEAKLife Science — Total revenues
——

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories's life science — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories's life science — net sales?
Bio-Rad Laboratories (BIO) reported life science — net sales of $228.5M in Q1 2026.
How has Bio-Rad Laboratories's life science — net sales changed year-over-year?
Bio-Rad Laboratories's life science — net sales decreased by 0.0% year-over-year, from $228.6M to $228.5M.
What is the long-term trend for Bio-Rad Laboratories's life science — net sales?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's life science — net sales has grown at a -7.6% compound annual growth rate (CAGR), from $1.4B to $1.02B.
What does life science — net sales mean?
Total revenue earned from the Life Science business segment after accounting for discounts and returns.
How do you interpret life science — net sales?
Higher sales indicate strong market adoption and competitive positioning in the life science research and production sectors.
How does life science — net sales compare across companies?
Key performance indicator for all life science and diagnostics companies.